Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
Data up to Jan 2025
Total Citations Per Year
Abstract
References (77)
Definition and classification of cancer cachexia: an international consensus
2011 • 4,715 citations
Epidemiology of Sarcopenia among the Elderly in New Mexico
1998 • 3,805 citations
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
2008 • 2,734 citations
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 • 2,226 citations
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
2008 • 1,819 citations
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
2004 • 1,489 citations
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography
1998 • 1,418 citations
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009 • 999 citations
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 • 922 citations
An overview of sarcopenia: facts and numbers on prevalence and clinical impact
2010 • 760 citations
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
2011 • 738 citations
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
2012 • 717 citations
Visceral abdominal-fat accumulation associated with use of indinavir
1998 • 717 citations
Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
2014 • 655 citations
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
2009 • 622 citations
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
2014 • 584 citations
Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity
2007 • 548 citations
Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy
2001 • 532 citations
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
2007 • 516 citations
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
2015 • 495 citations
Sarcopenic obesity: A Critical appraisal of the current evidence
2012 • 494 citations
Lean Tissue Imaging
2014 • 464 citations
Functional Compromise Reflected by Sarcopenia, Frailty, and Nutritional Depletion Predicts Adverse Postoperative Outcome After Colorectal Cancer Surgery
2014 • 453 citations
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
2015 • 451 citations
Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
2010 • 429 citations
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
2013 • 428 citations
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
2011 • 385 citations
Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma
2014 • 352 citations
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer
2015 • 323 citations
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
2012 • 284 citations
Obesity paradox in cancer: new insights provided by body composition
2014 • 282 citations
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
2010 • 273 citations
Ethnicity‐related skeletal muscle differences across the lifespan
2009 • 264 citations
The Clinical Guide to Oncology Nutrition
2000 • 262 citations
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
2011 • 258 citations
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
2014 • 253 citations
Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma
2014 • 252 citations
Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer
2015 • 248 citations
The emerging role of computerized tomography in assessing cancer cachexia
2009 • 243 citations
Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma
2013 • 237 citations
Sarcopenic Obesity: Does Muscle Loss Cause Fat Gain?: Lessons from Rheumatoid Arthritis and Osteoarthritisa
2000 • 229 citations
Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
2014 • 224 citations
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
2013 • 216 citations
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
2013 • 211 citations
Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials
2014 • 192 citations
Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer
2014 • 191 citations
Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food
2011 • 190 citations
Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer
2015 • 174 citations
Cancer-Associated Cachexia and Underlying Biological Mechanisms
2006 • 171 citations
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
2015 • 157 citations
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
2010 • 152 citations
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
2013 • 140 citations
Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery
2015 • 133 citations
Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
2015 • 133 citations
Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity
2011 • 129 citations
Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
2015 • 127 citations
The Prevalence of Sarcopenia in Patients With Respiratory Failure Classified as Normally Nourished Using Computed Tomography and Subjective Global Assessment
2013 • 125 citations
Nutritional support of the oncology patient
2013 • 121 citations
Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia
2012 • 118 citations
Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma
2015 • 117 citations
Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
2014 • 115 citations
Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy
2006 • 108 citations
Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study
2013 • 97 citations
Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib
2014 • 92 citations
Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer
2015 • 90 citations
A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer
2012 • 84 citations
Assessment of Nutritional Status in Cancer – The Relationship Between Body Composition and Pharmacokinetics
2013 • 77 citations
Sarcopenia and Physical Function: In Overweight Patients with Advanced Cancer
2013 • 73 citations
Automated segmentation of muscle and adipose tissue on CT images for human body composition analysis
2009 • 66 citations
Habitual Myofibrillar Protein Synthesis Is Normal in Patients with Upper GI Cancer Cachexia
2014 • 66 citations
Body composition in chemotherapy
2013 • 64 citations
The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer
2014 • 48 citations
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients
2014 • 47 citations
Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls
1997 • 43 citations
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
2015 • 36 citations
Dietary Patterns of Patients: With Advanced Lung or Colorectal Cancer
2012 • 27 citations
Nutritional advances in patients with respiratory diseases
2015 • 12 citations
Cited By (0)
No citing papers found in database